CYduct Diagnostics, Inc.
CYDX
$0.20
$0.000.00%
OTC PK
| 03/31/2012 | 12/31/2011 | 09/30/2011 | 06/30/2011 | 03/31/2011 | |
|---|---|---|---|---|---|
| Net Income | 11.20% | 59.54% | 139.65% | 63.39% | -17.98% |
| Total Depreciation and Amortization | -- | -100.00% | -60.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 330.01% | -252.03% | 628.57% | -96.63% | -26.47% |
| Change in Net Operating Assets | -4,824.51% | 93.38% | -224.29% | -36.95% | 735.92% |
| Cash from Operations | -1,120.00% | -431.25% | 96.59% | -1,440.00% | 110.20% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -30.00% | 40.68% | -490.00% | 35.48% | -108.31% |
| Issuance of Common Stock | 681.70% | -1.29% | -63.10% | 3,718.18% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,231.33% | 124.32% | -90.75% | 2,100.00% | -104.55% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,333.33% | -114.29% | 130.43% | -560.00% | -84.54% |